Published in Pain Pract on September 01, 2006
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol (2011) 1.21
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res (2013) 1.03
Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain (2013) 1.02
Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord (2010) 1.02
Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int (2009) 0.92
Trigeminal antihyperalgesic effect of intranasal carbon dioxide. Life Sci (2010) 0.92
Treatment of trigeminal neuralgia: role of radiofrequency ablation. J Pain Res (2010) 0.88
Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain (2013) 0.83
Pharmacological versus microvascular decompression approaches for the treatment of trigeminal neuralgia: clinical outcomes and direct costs. J Pain Res (2011) 0.83
Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. J Headache Pain (2015) 0.82
Cuneus and fusiform cortices thickness is reduced in trigeminal neuralgia. J Headache Pain (2014) 0.80
Osteoporosis in the jawbones: a correlative factor of primary trigeminal neuralgia? Med Sci Monit (2014) 0.80
Percutaneous trigeminal ganglion balloon compression rhizotomy: experience in 27 patients. ScientificWorldJournal (2012) 0.79
Trigeminal neuralgia. BMJ Clin Evid (2014) 0.79
Atypical Trigeminal Neuralgia: A Rare Neurological Manifestation of Systemic Lupus Erythematosus. Am J Case Rep (2017) 0.78
Grading the intensity of nondental orofacial pain: identification of cutoff points for mild, moderate, and severe pain. J Pain Res (2015) 0.78
Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics. Pain Res Treat (2014) 0.78
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia. J Phys Ther Sci (2013) 0.77
Diagnosis, medication, and surgical management for patients with trigeminal neuralgia: a qualitative study. Acta Neurochir (Wien) (2015) 0.76
Osteopathic manipulative treatment: novel application to dermatological disease. J Clin Aesthet Dermatol (2012) 0.76
Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag (2015) 0.75
Chronic Orofacial Pain: Burning Mouth Syndrome and Other Neuropathic Disorders. J Pain Manag Med (2017) 0.75
Add-on treatment with pregabalin for patients with uncontrolled neuropathic pain who have been referred to pain clinics. Clin Drug Investig (2014) 0.75
Percutaneous trigeminal ganglion radiofrequency thermocoagulation alleviates anxiety and depression disorders in patients with classic trigeminal neuralgia: A cohort study. Medicine (Baltimore) (2016) 0.75
Orofacial pain - an update on diagnosis and management. Br Dent J (2017) 0.75
DEEP Study: does EQ-5D-5L measure the impacts of persistent oro-facial pain? J Oral Rehabil (2015) 0.75
The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976) (2012) 1.92
Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage (2005) 1.89
How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain (2010) 1.80
Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain (2005) 1.79
Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain (2005) 1.53
Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications (2006) 1.17
Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy. J Pain Symptom Manage (2005) 1.16
A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing (2006) 1.14
Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med (2009) 1.11
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin (2009) 1.06
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy (2011) 1.05
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res (2013) 1.03
Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain (2006) 1.02
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. J Med Econ (2011) 0.99
Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes (2012) 0.99
Assessing dimensionality and responsiveness of outcomes measures for patients with low back pain. Pain Pract (2011) 0.98
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy. Diabetes Metab Syndr Obes (2011) 0.97
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence (2013) 0.95
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin (2009) 0.94
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord (2010) 0.94
Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. BMC Musculoskelet Disord (2011) 0.92
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Clin Ther (2007) 0.91
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract (2013) 0.91
Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation. Pain Med (2014) 0.91
Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother (2004) 0.88
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med (2009) 0.88
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther (2006) 0.88
Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes (2008) 0.88
Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract (2008) 0.88
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pract (2012) 0.87
Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Vasc Nurs (2005) 0.86
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. Curr Med Res Opin (2010) 0.84
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. BMC Geriatr (2009) 0.84
Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results. Pain Pract (2009) 0.83
Treatment of peripheral neuropathic pain: a simulation model. Eur J Pain (2005) 0.83
Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Pract (2008) 0.82
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain (2007) 0.82
Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med (2011) 0.82
Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther (2011) 0.81
Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin. Pain Med (2011) 0.81
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective. Eur J Health Econ (2009) 0.81
Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord (2010) 0.81
Acceptable, manageable, and tolerable days: patient daily goals for medication management of persistent pain. J Pain Symptom Manage (2004) 0.80
Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases. Pain Pract (2008) 0.80
Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Am J Manag Care (2010) 0.80
Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury. J Pain Res (2013) 0.79
Relationship between patient-reported disease severity and other clinical outcomes in osteoarthritis: a European perspective. J Med Econ (2011) 0.79
Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia. Health Qual Life Outcomes (2009) 0.78
Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract (2008) 0.77
Functional Impairment Is a Risk Factor for Knee Replacement in the Multicenter Osteoarthritis Study. Clin Orthop Relat Res (2015) 0.77
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia. Clin Ther (2003) 0.77
Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline. Pain Pract (2006) 0.77
Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin. Epilepsy Res (2012) 0.76
Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia. Qual Life Res (2010) 0.76
Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life. J Pain Symptom Manage (2003) 0.76
Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events. Curr Med Res Opin (2015) 0.75
Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability. J Occup Environ Med (2016) 0.75